Medtecs posted FY2025 revenue of USD 78.9 million, up 45.1%, while net loss narrowed to USD 4.8 million. Gross profit rose 80.4% to USD 12.4 million, and loss per share was 0.887 US cents for FY2025. The company said the revenue increase was driven by new OEM customers (USD 6.8 million of sales), higher demand from regular OEM customers, and additional USD 13.5 million of nitrile glove sales following the re-acquisition of its glove factory in Cambodia. Medtecs also completed the acquisition of RMKH Glove Pte. Ltd. on 28 May 2025, with RMKH Group contributing USD 14.0 million of revenue for the seven-month period from acquisition date. As of 31 Dec 2025, Medtecs reported total assets of USD 145.9 million, cash and bank balances of USD 15.5 million, and bank loans of USD 17.5 million. No dividend was recommended for FY2025, as the company cited a focus on working capital requirements and potential expansion projects.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medtecs International Corporation Ltd. published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: 4FYUIV810GYJES0M) on February 26, 2026, and is solely responsible for the information contained therein.